I did some research on previous quarterlies. It looks like the revenue came from a product they had called newly but then decided to sell that and focus on Tali. They made revenue from newly as well as the sale of newly, then it looked like they also made revenue by working with psychologists to get Tali train commercialised. Then it looked like from mid 2019 revenue started to decline. Now with the price drop of Tali train and the commercialisation of Tali detect along with the heavy promotional activity we should see revenue increase again.
- Forums
- ASX - By Stock
- TD1
- Tali Health 2020
Tali Health 2020, page-1434
Featured News
Add TD1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.295M |
Open | High | Low | Value | Volume |
0.1¢ | 0.1¢ | 0.1¢ | $2K | 2M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 20137147 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 15628165 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 20137147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 15628165 | 19 |
0.003 | 60436031 | 11 |
0.004 | 185025 | 1 |
0.005 | 4000000 | 1 |
0.006 | 250000 | 1 |
Last trade - 14.07pm 19/11/2024 (20 minute delay) ? |
Featured News
TD1 (ASX) Chart |